FDA Recalls Specific Primidone Batch Due to Contamination

A specific lot of the anti-seizure drug Primidone was recalled May 27, 2024. The recall targets Primidone Tablets, USP, 50 mg, packaged in a 100-tablet carton with 10 unit-dose blisters. The recall was initiated by Amerisource Health Services LLC. Routine testing found the drug’s active pharmaceutical ingredient (API) contained trace amounts of a different API called acemetacin.

Immediate Steps for Patients and Caregivers

Patients using this medication should not stop taking it abruptly. Sudden discontinuation of an anti-seizure medication like primidone can cause serious withdrawal seizures. The first action is to check your medication packaging. Affected units have Carton NDC 68084-202-01 and Individual Dose NDC 68084-202-11.

If your package matches these identifiers, contact your prescribing physician or pharmacy immediately. They can confirm if your specific prescription is from the recalled lot and arrange for a replacement. The recalled product should be returned to your pharmacy for proper disposal. The FDA advises consumers with medical questions to contact their healthcare provider. Questions about the return can go to Amerisource at 855-846-2542.

Acemetacin Contamination Poses Specific Kidney and Gastrointestinal Risks

Acemetacin is a non-steroidal anti-inflammatory drug (NSAID) not approved for use in the United States. Its presence in a drug intended for long-term neurological management is a significant concern. For patients on primidone, unintended exposure to an NSAID carries two primary risks.

First, NSAIDs can cause kidney injury, especially with repeated exposure. This risk is higher in older adults or individuals with pre-existing kidney issues. Second, acemetacin, like other NSAIDs, can irritate the stomach and intestinal lining, potentially leading to ulcers or bleeding. These effects are problematic for anyone, but pose a greater threat to older populations who may already have age-related declines in kidney function or use other medications that affect the gut.

Why Drug Purity is a Foundational Concern for Longevity

This recall illustrates a core principle in medical science: predictable, pure interventions are essential. Primidone is often used for a lifetime to manage epilepsy, particularly in older adults. Introducing an unknown, unintended chemical into a chronic therapy disrupts the careful balance of managing a neurological condition.

Dr. Sean Hennessy, a pharmacoepidemiologist at the University of Pennsylvania, notes that “unanticipated drug exposures complicate the assessment of treatment effects and side effects, making it difficult to distinguish the cause of new symptoms.” For a field focused on extending healthspan, consistency and accuracy in medication are non-negotiable. Contaminants can introduce variables that accelerate, rather than slow, age-related organ decline.

While recalls for contamination are relatively rare, they highlight the importance of robust manufacturing oversight. Patients and physicians must remain vigilant about verifying medication sources and reporting unexpected side effects.

Source:
FDA Safety Alerts